Shire Delivers Record Quarterly Revenues And Non GAAP Diluted Earnings Per ADS Up 42%.

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Increases Non GAAP diluted earnings per ADS guidance to low-to-mid thirty percent growth in 2014. July 18, 2014 – Shire (LSE: SHP, NASDAQ: SHPG) announces unaudited results for the three months to June 30, 2014.

 Financial Highlights Q2 2014 Growth(1) Product sales $1,470 million +22%(2) Total revenues $1,502 million +20% Non GAAP operating income $630 million +32% US GAAP operating income from continuing operations $338 million -14% Non GAAP EBITDA margin (excluding royalties & other revenues)(3) 44% n/a US GAAP net income margin(4) 35% n/a Non GAAP diluted earnings per ADS $2.67 +42% US GAAP diluted earnings per ADS $2.66 +96% Non GAAP cash generation $659 million +76% Non GAAP free cash flow $830 million +245% US GAAP net cash provided by operating activities $834 million +223% 

For full access, please click here.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC